Nucala

List of products in the National Drug Code with proprietary name nucala. This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. Mepolizumab is also used to treat a certain immune system diseases (eosinophilic granulomatosis with polyangiitis-EGPA, hypereosinophilic syndrome-HES). It helps to control and prevent symptoms (such as wheezing, shortness of breath, runny nose, facial pain, tiredness) caused by these diseases. It works by decreasing the amount of certain white blood cells (eosinophils) which may cause these diseases. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0173-0881Nucala MepolizumabInjection, Powder, For SolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
0173-0892Nucala MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
0173-0904Nucala MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug